CUREator Portfolio

Preclinical Stream
Alkira Bio
AAVec Bio
AMT Bio
Carsinosa
Cassowary Pharmaceuticals
Cincera Therapeutics
CoraMetix
Currus Biologics
Denteric
DesmoX
FLEX Immunotherapeutics
Fovero Therapeutics
Frontier Inflammasome Therapeutics
Genium
GILZRx
Kimaritec
Micromune Therapeutics
Mirugen
MPI Biotech
Myostellar
Nelcanen Therapeutics
Omega-One Therapeutics
Phrenix Therapeutics
Prokardia
Proxima Bio
RAGE Biotech
Setonix Pharmaceuticals
Sycura Therapeutics
xCystence Bio
Clinical Stream
Alyra Biotech
Axelia Oncology
Azura Ophtalmics
George Medicines
Liperate Therapeutics
OccuRx
Cyteph
Exosome Biosciences
ENA Respiratory
GPN Vaccines
OncoStrike Biopharma
PolyActiva
Respirion Pharmaceuticals
Health Security Stream
BioBandage
Cytophenix
Flavivirus vaccine platform
Myrio Therapeutics
Polynucleotides platform
Minimising Antimicrobial Resistance Stream
Kraken coding
Liquid crystal nanoparticles
Nasal therapy for otitis media | SpritzOM
Rescuing frontline antibiotics
SMART digital health app

Contact

Brandon Biocatalyst is managed by Brandon Capital

Melbourne

Level 9, 31 Queen Street

Melbourne VIC 3000

Phone +61 3 9657 0700

Email: info@brandonbiocatalyst.com


Sydney

Suite 2.05, 1 York Street

Sydney NSW 2000

Phone +61 2 8227 7080

Email: info@brandonbiocatalyst.com


For media inquiries

Kirrily Davis

kdavis@brandoncapital.com.au

+61 401 220 228


©2025 BioCatalyst Copyright